The synthesis of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex complicated chemical process. Preliminary routes focused on protein fragment coupling, utilizing solid-phase production methodologies to build the long protein sequence. Subsequent research has explored different approaches, including enzym